Peripherally Inserted Central Catheters Market Size & Forecasts 2026-2035, By Segments (Product, Lumen, End-use, Applications), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (BD, Teleflex, Cook Medical, Medtronic, ICU Medical)
Market Size and Growoth Outlook
Peripherally Inserted Central Catheters Market size is projected to expand significantly, moving from USD 1.52 billion in 2025 to USD 4.01 billion by 2035, with a CAGR of 10.2% during the 2026-2035 forecast period. The expected revenue for 2026 is USD 1.66 billion.
Get more details on this report
Request Free Sample ReportPeripherally Inserted Central Catheters Market Intelligence Snapshot
Regional Market Dynamics
Segment Momentum
Market Expansion Drivers
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Regional and Segment Outlook
Market Growth Drivers and Industry Trends
Rising Demand for PICCs in Chronic Illness Treatments
The peripherally inserted central catheters market is significantly influenced by the increasing prevalence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases, which require long-term venous access for therapies. Organizations like the World Health Organization have reported a steady rise in chronic conditions, prompting healthcare providers to seek reliable solutions for patient management. This trend is fostering a shift towards peripherally inserted central catheters (PICCs), which offer a less invasive alternative to traditional central lines. The growing demand presents strategic opportunities for established players to enhance their product offerings and for new entrants to innovate in catheter design and usability, particularly in addressing the specific needs of chronic illness patients. Observing the evolving treatment protocols emphasizes the necessity for continuous improvement in catheter technology to ensure patient safety and comfort.
Increasing Use of Image-Guided Insertion Techniques
The integration of advanced imaging technologies into the insertion processes of peripherally inserted central catheters is reshaping the market landscape. Techniques such as ultrasound and fluoroscopy are becoming standard practice, as evidenced by guidelines from the Centers for Disease Control and Prevention, which advocate for image guidance to reduce complications. This evolution not only enhances the precision of catheter placement but also improves patient outcomes, driving higher adoption rates among healthcare facilities. For established companies, investing in training and technology that supports these techniques can enhance their competitive edge, while new entrants have the opportunity to develop innovative solutions that simplify the insertion process. The ongoing advancements in imaging technology indicate a promising direction for the peripherally inserted central catheters market, emphasizing the need for alignment with clinical best practices.
Integration of Antimicrobial and Safety-Coated Catheters
The rising focus on infection prevention in healthcare settings is propelling the demand for antimicrobial and safety-coated catheters within the peripherally inserted central catheters market. Regulatory bodies, including the Food and Drug Administration, have underscored the importance of reducing catheter-related bloodstream infections (CRBSIs), leading to a surge in the development of catheters designed with antimicrobial properties. This trend not only addresses patient safety concerns but also aligns with broader healthcare goals of improving quality and reducing costs associated with hospital-acquired infections. Established players are well-positioned to leverage their R&D capabilities to enhance product safety, while new entrants can explore niche markets focusing on innovative coating technologies. The ongoing commitment to infection control in healthcare settings suggests a sustained demand for these advanced catheter solutions, reinforcing their critical role in future market dynamics.
Industry Restraints:
Clinical Adoption Barriers
The peripherally inserted central catheters (PICC) market faces significant clinical adoption barriers that hinder its growth. Many healthcare professionals exhibit hesitance to adopt these devices due to concerns over complications such as infections and thrombosis, which can lead to increased hospital stays and costs. According to a study published in the Journal of Vascular Access, the risk of catheter-related infections remains a critical issue, deterring clinicians from recommending PICCs over traditional central lines. This reluctance is compounded by varying institutional protocols and the lack of standardized training for insertion and maintenance, leading to operational inefficiencies. As a result, both established companies and new entrants must navigate a complex landscape of clinical education and advocacy to foster broader acceptance, which may slow market penetration and innovation.
Regulatory Scrutiny and Compliance Challenges
The regulatory landscape for peripherally inserted central catheters is marked by stringent compliance requirements that can stifle innovation and market entry. The U.S. Food and Drug Administration (FDA) has implemented rigorous pre-market approval processes that require extensive clinical data to demonstrate safety and efficacy. This scrutiny can delay product launches, as seen with several manufacturers who have faced prolonged review periods due to the need for additional studies. Furthermore, compliance with evolving regulations, including those related to patient safety and device tracking, imposes significant operational burdens on companies. This regulatory environment not only challenges established firms in maintaining their market positions but also discourages new entrants who may lack the resources to navigate these complexities. Looking ahead, as regulatory frameworks continue to evolve in response to emerging safety concerns, market participants will need to adapt swiftly to maintain competitiveness in the PICC market.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for PICCs in chronic illness treatments | 1.20% | Short term (≤ 2 yrs) | North America, Europe (spillover: Asia Pacific) | High | Fast |
| Increasing use of image-guided insertion techniques | 0.80% | Medium term (2–5 yrs) | Asia Pacific, Europe (spillover: Latin America) | Medium | Moderate |
| Integration of antimicrobial and safety-coated catheters | 0.60% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | Medium | Slow |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America Market Statistics:
North America represented more than 46.35% of the global peripherally inserted central catheters market in 2025, establishing itself as both the largest and fastest-growing region. This dominance can be attributed to the high adoption of advanced medical technologies within healthcare facilities, reflecting a significant shift in demand towards more efficient and effective patient care solutions. The region's focus on innovation, supported by robust regulatory frameworks and a strong emphasis on technological advancements, has led to increased spending on healthcare infrastructure. Additionally, the evolving consumer preferences towards minimally invasive procedures and enhanced patient outcomes have further driven market growth. According to the American Hospital Association, the integration of cutting-edge medical devices in hospitals has become a priority, reinforcing North America's leadership in this sector. Looking ahead, the region offers substantial opportunities for stakeholders in the peripherally inserted central catheters market due to its commitment to healthcare excellence and continuous improvement in medical practices.
The United States anchors the North American peripherally inserted central catheters market, characterized by its extensive network of advanced medical facilities. The country's regulatory environment fosters innovation, allowing for rapid adoption of new technologies that enhance patient care. For instance, the U.S. Food and Drug Administration has streamlined approval processes for innovative medical devices, enabling quicker access to advanced peripherally inserted central catheters that improve clinical outcomes. This has led to a competitive landscape where companies are increasingly investing in research and development to meet the growing consumer demand for high-quality healthcare solutions. As reported by the Centers for Medicare & Medicaid Services, the shift towards value-based care is further incentivizing healthcare providers to adopt advanced catheter technologies, ultimately positioning the U.S. as a pivotal player in the regional market.
Canada also plays a significant role in the North American peripherally inserted central catheters market, with a healthcare system that emphasizes patient-centered care and innovation. The Canadian healthcare landscape is marked by a collaborative approach between public and private sectors, facilitating the integration of advanced medical technologies. The Canadian Agency for Drugs and Technologies in Health has been instrumental in evaluating and recommending new medical devices, including peripherally inserted central catheters, which aligns with the country's commitment to improving healthcare delivery. This regulatory support, combined with a growing awareness of the benefits of minimally invasive procedures among healthcare providers, is driving market growth. As Canada continues to enhance its healthcare infrastructure, it reinforces the overall strength of the North American market, presenting strategic opportunities for stakeholders in the peripherally inserted central catheters sector.
Asia Pacific Market Analysis:
Asia Pacific emerged as the fastest-growing region in the peripherally inserted central catheters market, posting a robust CAGR of 12%. The increasing prevalence of chronic diseases across this region significantly boosts demand for these medical devices, as healthcare providers seek efficient solutions for long-term patient care. This surge in demand is driven by a combination of factors, including an aging population, rising healthcare expenditures, and advancements in medical technology. Countries in this region are increasingly prioritizing healthcare infrastructure, leading to enhanced access to advanced medical devices such as peripherally inserted central catheters. For instance, the World Health Organization has reported a growing focus on improving healthcare delivery systems in Asia Pacific, which further supports the adoption of innovative medical solutions. As a result, this region presents substantial opportunities for growth and investment in the peripherally inserted central catheters market.
Japan plays a pivotal role in the Asia Pacific peripherally inserted central catheters market, characterized by its advanced healthcare infrastructure and high demand for quality medical devices. The increasing chronic disease prevalence in Japan, particularly cardiovascular and oncological conditions, drives the need for effective long-term intravenous access solutions. Japanese healthcare providers are increasingly adopting innovative technologies to enhance patient outcomes, with a focus on minimizing complications associated with catheter use. The Ministry of Health, Labour and Welfare in Japan has been proactive in implementing policies that encourage the use of advanced medical technologies, further fostering a conducive environment for the growth of the peripherally inserted central catheters market. This strategic positioning not only enhances Japan's market presence but also aligns with regional trends, reinforcing the Asia Pacific's leadership in this sector.
China is also a significant player in the Asia Pacific peripherally inserted central catheters market, driven by its rapidly expanding healthcare sector and increasing investment in medical technology. The country's growing chronic disease burden, particularly diabetes and cancer, necessitates the use of peripherally inserted central catheters for effective treatment. In response, Chinese healthcare providers are enhancing their procurement strategies to ensure access to high-quality medical devices. The National Health Commission of China has emphasized the importance of improving healthcare services, which includes the integration of advanced medical devices into treatment protocols. As a result, China's proactive approach to healthcare innovation and its substantial market size position it as a key contributor to the overall growth of the peripherally inserted central catheters market in Asia Pacific. This dynamic landscape indicates a promising future for stakeholders looking to capitalize on the region's expanding healthcare needs.
Europe Market Trends:
Europe held a commanding share in the peripherally inserted central catheters market, driven by a robust healthcare infrastructure and increasing demand for minimally invasive procedures. The region's significance is underscored by its advanced technological landscape and a strong emphasis on patient-centric care, which has fostered innovation in catheter design and functionality. Recent shifts in consumer preferences towards outpatient care and enhanced safety protocols have further fueled market growth. According to the European Society of Cardiology, the rise in chronic diseases necessitating long-term venous access is propelling investment in this segment. Moreover, regulatory bodies like the European Medicines Agency are promoting stringent safety standards, enhancing the market's credibility and attractiveness for investment. With the ongoing digital transformation in healthcare and an increasing focus on sustainability, Europe presents substantial opportunities for stakeholders in the peripherally inserted central catheters market.
Germany plays a pivotal role in the European peripherally inserted central catheters market, characterized by its significant healthcare expenditure and a high prevalence of chronic illnesses. The country's strong regulatory framework, coupled with a commitment to innovation, has led to increased adoption of advanced catheter technologies. For instance, the Federal Ministry of Health has supported initiatives aimed at improving patient outcomes, which has spurred the development of next-generation catheters. Furthermore, the competitive landscape is marked by leading manufacturers such as B. Braun Melsungen AG, which has reported a substantial increase in sales due to the growing demand for safe and effective catheter solutions. This dynamic environment positions Germany as a key driver of growth in the region, aligning with broader opportunities in the peripherally inserted central catheters market.
France also maintains a notable presence in the peripherally inserted central catheters market, influenced by a strong emphasis on healthcare innovation and patient safety. The country’s healthcare system is increasingly adopting advanced medical technologies, supported by governmental initiatives aimed at enhancing healthcare delivery. The French National Authority for Health has been instrumental in promoting the use of innovative medical devices, which has led to a rise in catheter utilization rates. Companies like Teleflex Incorporated have reported significant growth in their French operations, driven by the increasing preference for peripherally inserted central catheters in outpatient settings. This trend reflects a broader shift towards efficiency and patient-centered care in France, reinforcing the country’s strategic importance in the regional market and creating further opportunities for growth in the peripherally inserted central catheters market.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Segment Leadership and Growth Trends
Peripherally Inserted Central Catheters Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnalysis by Product Segment
The peripherally inserted central catheters market is led by the power injected PICC segment, which dominated the segment with a 47.38% share in 2025. This leadership is primarily attributed to its suitability for contrast-enhanced imaging procedures, making it a preferred choice among healthcare professionals for diagnostic and therapeutic applications. The growing emphasis on minimally invasive techniques and the increasing demand for advanced imaging capabilities have further propelled this segment's prominence. Additionally, the shift towards digital health solutions and improvements in supply chain logistics have enhanced accessibility and adoption rates. Established firms can leverage this segment's growth by investing in innovative technologies, while emerging players can capitalize on the increasing demand for specialized products. Given the ongoing advancements in imaging technologies and the rising prevalence of chronic diseases requiring complex interventions, this segment is expected to maintain its relevance in the near to medium term.
Analysis by Lumen Segment
The peripherally inserted central catheters market features the double lumen segment, which captured over 50.47% share of the overall market in 2025. Its leadership stems from its versatility for multiple simultaneous infusions, catering to the diverse needs of patients undergoing complex treatments. This adaptability aligns with evolving customer preferences for streamlined care pathways and enhanced patient safety. Furthermore, regulatory advancements and the push for standardized practices in vascular access have reinforced the demand for double lumen catheters. The segment presents strategic advantages for established companies looking to expand their product lines, while also offering opportunities for startups focusing on innovative designs. With the increasing complexity of patient care and the rise of personalized medicine, the double lumen segment is poised to remain a critical component of the peripherally inserted central catheters market.
Analysis by End-use Segment
The peripherally inserted central catheters market is significantly influenced by the hospitals segment, which represented more than 60.14% of the market share in 2025. This dominance is driven by the high volume of inpatient vascular procedures performed in hospital settings, where the need for efficient and reliable vascular access solutions is paramount. The ongoing transformation in healthcare delivery, with a focus on improving patient outcomes and reducing hospital stays, has further solidified the role of hospitals in this market. Additionally, the integration of advanced technologies and training programs for healthcare professionals has enhanced the efficacy of catheter use in hospitals. This segment offers substantial opportunities for both established firms and new entrants to innovate and differentiate their offerings. As hospitals continue to adopt advanced medical technologies and prioritize patient-centric care models, the hospitals segment is expected to remain a key driver of growth in the peripherally inserted central catheters market.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Power injected PICC, Conventional PICC, Neonatal PICC | ||
| Lumen | Single, Double, Multiple | ||
| End-use | Hospitals, Ambulatory surgical centers, Homecare settings, Other end-users | ||
| Applications | Chemotherapy, Long-term IV Infusion, Parenteral nutrition, Blood transfusion, Other applications |
Competitive Landscape and Market Positioning
Key players in the peripherally inserted central catheters market include BD, Teleflex, Cook Medical, Medtronic, ICU Medical, B. Braun, AngioDynamics, Vygon, Smiths Medical, and Merit Medical Systems. These companies are distinguished by their innovative approaches and extensive product portfolios, which cater to a diverse range of clinical needs. BD, for instance, is recognized for its strong emphasis on research and development, leading to cutting-edge catheter designs that enhance patient safety. Similarly, Teleflex has established itself as a formidable player through its commitment to quality and regulatory compliance, ensuring that its products meet stringent healthcare standards. Other key players like Medtronic and ICU Medical maintain significant market presence by leveraging advanced technologies and fostering strong relationships with healthcare providers, thereby influencing market trends and setting benchmarks for quality and efficiency in catheter solutions.
The competitive landscape of the peripherally inserted central catheters market is characterized by dynamic interactions among the top players, who continually seek to enhance their market positioning through various strategic initiatives. Companies like Cook Medical and AngioDynamics have been proactive in expanding their product lines and enhancing their technological capabilities, which not only fortifies their competitive edge but also drives innovation within the sector. Collaborations between firms, such as those seen with B. Braun and Vygon, facilitate shared expertise and resource optimization, leading to the development of novel products that address evolving healthcare demands. This environment of strategic maneuvering fosters a culture of continuous improvement, where companies are motivated to enhance their offerings and respond adeptly to market shifts, thereby maintaining a competitive advantage.
Strategic / Actionable Recommendations for Regional Players
In North America, market players are encouraged to explore synergies through partnerships with healthcare institutions and technology firms, focusing on integrating digital health solutions into catheter management systems. This approach not only enhances patient care but also positions companies as leaders in innovative healthcare delivery.
In the Asia Pacific region, tapping into emerging markets with tailored catheter solutions that address local healthcare challenges could yield significant growth opportunities. Collaborating with regional distributors to understand specific market needs and preferences will be crucial for effective penetration and sustained success.
In Europe, leveraging advancements in biocompatible materials and minimally invasive technologies can set companies apart in a competitive landscape. Engaging in research initiatives with academic institutions to foster innovation will not only enhance product offerings but also strengthen brand reputation among healthcare providers.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Peripherally Inserted Central Catheters Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Peripherally Inserted Central Catheters Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much revenue does the peripherally inserted central catheters market generate?
How much is the peripherally inserted central catheters industry expected to grow by 2035?
Which territory demonstrates the strongest presence in the peripherally inserted central catheters market?
Where has the peripherally inserted central catheters sector recorded the sharpest year-over-year increase?
How much is the power injected PICC segment expected to grow in the peripherally inserted central catheters industry beyond 2025?
What factors give double segment a competitive edge in the peripherally inserted central catheters sector?
Which is the largest sub-segment within the end-use segment for peripherally inserted central catheters industry?
What are the prominent companies operating in the peripherally inserted central catheters landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization